BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 29, 2009
View Archived Issues
Lilly and Incyte sign license and collaboration agreement for INCB-28050
Read More
Teva and OncoGenex sign license and collaboration agreement for OGX-011
Read More
Ipsen discloses preliminary data from phase I trial of BN-83495 in breast cancer
Read More
Ligand completes acquisition of Neurogen
Read More
pSivida reports 24-month results from phase III FAME study of Iluvien for DME
Read More
Bryan Oncor reports results of phase I trial of radiolabeled P-2045 in advanced lung cancer
Read More
Thallion to close phase II trial of TLN-4601 for glioblastoma multiforme
Read More
Applied NeuroSolutions and Lilly agree to increase the scope of their AD collaboration
Read More
FDA clears Dilon Diagnostics' GammaLoc for molecular imaging biopsy guidance
Read More
Solvay submits NDA in Japan for pancrelipase for pancreatic exocrine insufficiency
Read More
FDA approves Sanofi Pasteur's High-Dose Fluzone vaccine for people aged 65 years and older
Read More
FDA issues complete response letter for Pfizer's NDA for Lyrica in GAD
Read More
Janssen discovers novel antibacterial agents
Read More
Enanta Pharmaceuticals discloses NS3 protease inhibitors for HCV infection
Read More
GSK presents novel compounds for the treatment of anemia
Read More
Novel MAPKAP5 inhibitors in development at Galapagos for the treatment of RA
Read More
Merck & Co. developing novel BACE1 inhibitors for neurologic conditions
Read More
Gilead discovers novel NS5B inhibitors for the treatment HCV infections
Read More
Allergan claims prostanoid EP2 receptor activators for glaucoma therapy
Read More
Kappa-opioid receptor antagonists claimed by Janssen for treatment of addiction
Read More
Ferrous sulfate may improve restless legs syndrome symptoms
Read More
Interim study results suggest AE-37 vaccine may reduce breast cancer recurrence
Read More
BSI-201 added to gemcitabine/carboplatin improves survival in metastatic TNBC
Read More
Intercell initiates pediatric phase III study of Japanese encephalitis vaccine
Read More
FDA accepts for review Questcor's sNDA for H.P. Acthar Gel for infantile spasms
Read More